Oncology Companion Diagnostic Market

A companion diagnostic is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.

Oncology Companion Diagnostic Market contains market size and forecasts of Oncology Companion Diagnostic in Global, including the following market information:

• Global Oncology Companion Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Oncology Companion Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oncology Companion Diagnostic include Agilent Technologies, Inc., Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., ARUP Laboratories, Abbott, Myriad Genetics, Inc. and bioM rieux SA and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Oncology Companion Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oncology Companion Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Oncology Companion Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• Immunohistochemistry (IHC)
• In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
• Others

Global Oncology Companion Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Oncology Companion Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Pathology/Diagnostic Laboratory
• Academic Medical Center

Global Oncology Companion Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Oncology Companion Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Oncology Companion Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Oncology Companion Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Agilent Technologies, Inc.
• Illumina, Inc.
• Qiagen N.V.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• ARUP Laboratories
• Abbott
• Myriad Genetics, Inc.
• bioM rieux SA
• Invivoscribe, Inc.